FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2150152035> ?p ?o ?g. }

• W2150152035 endingPage "638" @default.
• W2150152035 startingPage "628" @default.
• W2150152035 abstract "To determine the effectiveness of radical radiotherapy in medically inoperable stage I/II non-small cell lung cancer (NSCLC) and the extent of treatment related morbidity.Randomised trials were sought by electronically searching the Cochrane Clinical Trials Register, and both randomised and non-randomised trials were sought by searching Medline and Excerpta Medica (Embase). Further studies were identified from references cited in those papers already identified by electronic searching. The studies included were those of patients of any age with stage I/II NSCLC receiving radiotherapy at a dose of >40 Gy in 20 fractions over 4 weeks or its radiobiological equivalent.Two randomised and 35 non-randomised studies were identified. One randomised and nine non-randomised studies did not meet the selection criteria, leaving one randomised and 26 non-randomised studies for analysis. In the randomised trial 2 year survival was higher following continuous hyperfractionated accelerated radiotherapy (CHART; 37%) than following 60 Gy in 30 fractions over 6 weeks (24%). An estimated 2003 patients were included in the 26 non-randomised studies; overall survival was 22-72% at 2 years, 17-55% at 3 years, and 0-42% at 5 years. Following treatment, 11-43% of patients died from causes other than cancer. Cancer specific survival was 54-93% at 2 years, 22-56% at 3 years, and 13-39% at 5 years. Complete response rates were 33-61% and local failure rates were 6-70%. Distant metastases developed in approximately 25% of patients. Better response rates and survival were seen in those with smaller tumours and in those receiving higher doses although the reasons for prescribing higher doses were not clearly stated. The outcome was worse in those with prior weight loss or poor performance status. Assessment of treatment related morbidity and effects on quality of life and symptom control were inconclusive because of the lack of prospective evaluation and paucity of data.No randomised trials compared a policy of immediate radical radiotherapy with palliative radiotherapy given when patients develop symptoms. In the absence of such trials, radical radiotherapy appears to result in a better survival than might be expected had treatment not been given. A substantial, though variable, proportion of patients died during follow up from causes other than cancer. The optimal radiation dose and treatment technique (particularly with respect to mediastinal irradiation) remain uncertain." @default.
• W2150152035 created "2016-06-24" @default.
• W2150152035 creator A5036327427 @default.
• W2150152035 creator A5086931161 @default.
• W2150152035 date "2001-08-01" @default.
• W2150152035 modified "2023-10-06" @default.
• W2150152035 title "Radical radiotherapy for stage I/II non-small cell lung cancer in patients not sufficiently fit for or declining surgery (medically inoperable): a systematic review" @default.
• W2150152035 cites W1506774621 @default.
• W2150152035 cites W1973277978 @default.
• W2150152035 cites W1979497535 @default.
• W2150152035 cites W1979538859 @default.
• W2150152035 cites W1979970921 @default.
• W2150152035 cites W1981969770 @default.
• W2150152035 cites W1989210471 @default.
• W2150152035 cites W1991345460 @default.
• W2150152035 cites W1993312546 @default.
• W2150152035 cites W2002089674 @default.
• W2150152035 cites W2002815320 @default.
• W2150152035 cites W2008810773 @default.
• W2150152035 cites W2014291266 @default.
• W2150152035 cites W2015119814 @default.
• W2150152035 cites W2019823097 @default.
• W2150152035 cites W2021329627 @default.
• W2150152035 cites W2022396173 @default.
• W2150152035 cites W2022774277 @default.
• W2150152035 cites W2031555443 @default.
• W2150152035 cites W2034440694 @default.
• W2150152035 cites W2035392216 @default.
• W2150152035 cites W2044021470 @default.
• W2150152035 cites W2046602311 @default.
• W2150152035 cites W2050608055 @default.
• W2150152035 cites W2051767374 @default.
• W2150152035 cites W2052984045 @default.
• W2150152035 cites W2054385160 @default.
• W2150152035 cites W2056012403 @default.
• W2150152035 cites W2056519805 @default.
• W2150152035 cites W2057604474 @default.
• W2150152035 cites W2057991314 @default.
• W2150152035 cites W2062375422 @default.
• W2150152035 cites W2062435034 @default.
• W2150152035 cites W2065102688 @default.
• W2150152035 cites W2068823914 @default.
• W2150152035 cites W2073456752 @default.
• W2150152035 cites W2075648713 @default.
• W2150152035 cites W2092769396 @default.
• W2150152035 cites W2094956930 @default.
• W2150152035 cites W2105956644 @default.
• W2150152035 cites W2137932274 @default.
• W2150152035 cites W2153734905 @default.
• W2150152035 cites W2159917472 @default.
• W2150152035 cites W2165046000 @default.
• W2150152035 cites W2337907029 @default.
• W2150152035 cites W2397034862 @default.
• W2150152035 cites W2418617595 @default.
• W2150152035 cites W2436362301 @default.
• W2150152035 cites W2462748410 @default.
• W2150152035 cites W2417037604 @default.
• W2150152035 doi "https://doi.org/10.1136/thorax.56.8.628" @default.
• W2150152035 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/1746110" @default.
• W2150152035 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11462066" @default.
• W2150152035 hasPublicationYear "2001" @default.
• W2150152035 type Work @default.
• W2150152035 sameAs 2150152035 @default.
• W2150152035 citedByCount "149" @default.
• W2150152035 countsByYear W21501520352012 @default.
• W2150152035 countsByYear W21501520352013 @default.
• W2150152035 countsByYear W21501520352014 @default.
• W2150152035 countsByYear W21501520352015 @default.
• W2150152035 countsByYear W21501520352016 @default.
• W2150152035 countsByYear W21501520352017 @default.
• W2150152035 countsByYear W21501520352018 @default.
• W2150152035 countsByYear W21501520352019 @default.
• W2150152035 countsByYear W21501520352020 @default.
• W2150152035 countsByYear W21501520352021 @default.
• W2150152035 countsByYear W21501520352022 @default.
• W2150152035 countsByYear W21501520352023 @default.
• W2150152035 crossrefType "journal-article" @default.
• W2150152035 hasAuthorship W2150152035A5036327427 @default.
• W2150152035 hasAuthorship W2150152035A5086931161 @default.
• W2150152035 hasBestOaLocation W21501520351 @default.
• W2150152035 hasConcept C121608353 @default.
• W2150152035 hasConcept C126322002 @default.
• W2150152035 hasConcept C141071460 @default.
• W2150152035 hasConcept C146357865 @default.
• W2150152035 hasConcept C151730666 @default.
• W2150152035 hasConcept C168563851 @default.
• W2150152035 hasConcept C2776256026 @default.
• W2150152035 hasConcept C509974204 @default.
• W2150152035 hasConcept C535046627 @default.
• W2150152035 hasConcept C71924100 @default.
• W2150152035 hasConcept C86803240 @default.
• W2150152035 hasConceptScore W2150152035C121608353 @default.
• W2150152035 hasConceptScore W2150152035C126322002 @default.
• W2150152035 hasConceptScore W2150152035C141071460 @default.
• W2150152035 hasConceptScore W2150152035C146357865 @default.
• W2150152035 hasConceptScore W2150152035C151730666 @default.
• W2150152035 hasConceptScore W2150152035C168563851 @default.
• W2150152035 hasConceptScore W2150152035C2776256026 @default.

• next